Strides Pharma board meeting scheduled for May 18, 2026 to approve FY2026 audited financial results and consider final dividend.
Trading window for designated persons closed since April 1, 2026 and will reopen 48 hours after results declaration.
Regulatory intimation filed under SEBI Listing Regulations Regulation 29 for mandatory board meeting disclosure.